ClinConnect ClinConnect Logo
Search / Trial NCT05997914

Storytelling for Reducing Gap in Anticoagulation Use in African Americans With Atrial Fibrillation

Launched by UNIVERSITY OF MASSACHUSETTS, WORCESTER · Aug 11, 2023

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

This is a multi-site research study including sites of both the University of Massachusetts Chan Medical School (UMass Memorial Healthcare System) and the University of Michigan Medical Center (Michigan).

Baseline call: During the baseline call, the investigators will obtain verbal informed consent. During the call, the investigators will also collect demographic information and measure health literacy, the latter using two validated single-item instruments the investigators have used before.

Randomization: The investigators will randomize patients to watch videos the investigators develo...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • African-American patients aged 18 or older with elevated stroke risk (CHA2DS2-VASc ≥2 for men and ≥3 for women) who are not currently on anticoagulation (AC) but for whom a cardiology provider or primary care provider at the two study sites recommended AC recently
  • Exclusion Criteria:
  • Non-African American and other non-Black patients under the age of 18 patients without an ICD-10 diagnostic code consistent with AF or atrial fibrillation or atrial flutter
  • Patient without a visit with a primary care provider, cardiovascular medicine specialist, or ambulatory care provider in the previous one year
  • Patient who is pregnant or a prisoner.
  • Patients with left atrial appendage surgery or device, hospice status, ongoing bleeding, and intracranial bleeding in intralobar territory

About University Of Massachusetts, Worcester

The University of Massachusetts Worcester is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the university integrates cutting-edge scientific inquiry with a commitment to improving patient outcomes. Its collaborative approach engages a diverse range of experts, fostering interdisciplinary research that addresses pressing health challenges. With a focus on ethical standards and regulatory compliance, the University of Massachusetts Worcester plays a pivotal role in translating scientific discoveries into practical applications that enhance medical practice and patient care.

Locations

Ann Arbor, Michigan, United States

Worcester, Massachusetts, United States

Jacksonville, Florida, United States

Worcester, Massachusetts, United States

Patients applied

0 patients applied

Trial Officials

Alok Kapoor, MD

Principal Investigator

UMass Chan Medical School

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported